Where supplies needed for the levonorgestrel or Yuzpe regimens of emergency contraception are not available, norethindrone combined oral contraceptives can be substituted.
Because the Yuzpe regimen of emergency contraception is at least partially effective when started up to 120 hours after unprotected intercourse, current protocols are too restrictive.
Serum and follicular fluid of women with polycystic ovary syndromecontain high levels of tumor necrosis factor–a and interleukin-6.
Extended spectrum prophylactic antibiotic treatment given at cesarean delivery shortens hospital stay and reduces the frequency of post–cesarean delivery endometritis and wound infections.
Perinatal outcome in twin–twin transfusion syndrome managed with amnioreduction techniques is directly related to stage at diagnosis and gestation at delivery.
The fasting plasma glucose test at the first prenatal visit is an inefficient screen for gestational diabetes.
A lower cesarean delivery rate is not associated with increased perinatal mortality but is associated with an increased risk of intracranial hemorrhage.
Pure isoflavonoids are not effective in alleviating subjectivemenopausal symptoms or improving quality of life in breast cancerpatients.
This population-based, case–control study explores the association of alcohol consumption with the risk of ovarian cancer.
Sperm chromosome aneuploidy, apoptosis, and abnormal morphologyare increased in some couples with unexplained recurrent pregnancy loss compared with the general population and fertile controls.
This prospective, multicenter study demonstrates that skewed X chromosome inactivation is not associated with recurrent miscarriage, nor is it predictive of a next pregnancy outcome.
United States training programs use supervised clinical experienceas their primary teaching and assessment tool for electronic fetal monitoring interpretation.
Prematurity and neonatal infection but not intrapartum hypoxia–ischemia are associated with neonatal neurologic morbidity in very low birth weight infants.
Noninvasive transabdominal uterine electromyography can be used to characterize labor and predict delivery in both term and preterm human patients.
Both the actual and ultrasound-estimated amniotic fluid volumesare increased with intravenous hydration.
Combined analysis of second-trimester maternal serum placental growth factor and vascular endothelial growth factor levels can identify patients at risk for developing severe, early-onset preeclampsia.
Unilateral cornual obstruction during hysterosalpingography is often resolved by rotating the patient such that the obstructed tube is more inferior.
Age, prior prolapse surgery, preoperative pelvic pain scores, and pelvic organ prolapse severity are independently associated with treatment choice in a predictable way.
Standardized vulvar observations of vaginal mucus discharge identify the days with the greatest likelihood of conception from intercourse in normal fertility and subfertility.
In second-trimester pregnancy termination for fetal abnormality, avaginal misoprostol regimen was 1.9 times more likely to result indelivery within 24 hours from commencement than an oral regimen.
Screening positive for Down syndrome indicated a possible higherrisk for trisomy 13 and a higher risk for spontaneous fetal loss but not other adverse outcomes.
The maternal response to low molecular weight heparin changes during pregnancy, showing less effect towards term.
Hemostasis was achieved with one dose of activated recombinant factor VII in a patient with life-threatening intractable bleeding after gynecologic surgery.
A successful treatment of life-threatening postpartum hemorrhage with recombinant factor VIIa is described.
In patients with postterm pregnancies, labor induction lowers therate of cesarean delivery without compromising perinatal outcomes.
Assessment of historical risk factors (such as history of preeclampsia, chronic hypertension, and diabetes) identifies women in whom aspirin therapy reduces perinatal death and preeclampsia.
Diagnosis and management of antiphospholipid syndrome in pregnancyrequire a full understanding of the maternal and fetal risks, as well as controversies raised by recent studies.
There is no evidence that "bust enhancing" herbal products are effective, and safety concerns exist.
Abstracts: ABSTRACTS Obstet Gynecol 2003 101: 1350-1352. [Full Text] [PDF]
Letters to the Editor: Clinical Evaluation of a "Hand Pump" Vacuum Delivery Device Martin L. Schwartz Obstet Gynecol 2003 101: 1353. [Full Text] [PDF] A Randomized Trial of Oral and Vaginal Misoprostol to Manage Delivery in Cases of Fetal Death Karine Kleinhaus, Stephanie Teal, Apichart Chittacharoen, Yongyoth Herabutya, Piyaporn Punyavachira Obstet Gynecol 2003 101: 1353-a-1354-a. [Full Text] [PDF] Cervical Cancer: Effect of Glandular Cell Type on Prognosis, Treatment, and Survival Michael Sindos, Narendra Pisal, Theresa Freeman-Wang, Albert Singer, Margaret Davy Obstet Gynecol 2003 101: 1354-1355. [Full Text] [PDF] Problems With Intrapartum Fetal Heart Rate Monitoring Interpretation and Patient Management Michael G. Ross Obstet Gynecol 2003 101: 1355-1356. [Full Text] [PDF]
To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.
